Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Anneliese Dodds, MP for Oxford East & Chair of the Labour Party, visited the University of Oxford to learn more about the impactful work happening across departments in the field of cancer research.

Anneliese Dodds MP visits the CRUK Cancer Centre
Anneliese Dodds MP visits the CRUK Cancer Centre

Anneliese Dodds, MP for Oxford East & Chair of the Labour Party, visited the Cancer Research UK Oxford Centre at the University of Oxford on the 26 November 2021 to tour the labs and buildings where cutting-edge cancer research is being undertaken, to drive patient-focused solutions to cancer challenges.

Anneliese engaged with researchers from across Oxford’s key cancer themes: the areas where Oxford academics are making the biggest impact through major scientific developments.

The visit formed part of a Cancer Research UK campaign to engage MPs in the important and impactful cancer research happening in cancer centres across the UK.

During Anneliese’s visit, she viewed demonstrations from across a range of scientific disciplines, beginning with a talk from our Early Detection theme. Anneliese met with Chunxiao Song at the Target Delivery Institute, whose TAPS technology is a major advancement in the field of early detection through simple and cheap blood-based testing.

Anneliese talking with Chunxiao Song, who works on TAPS: an early detection of cancer technology that uses blood-based testingAnneliese talking with Chunxiao Song, who works on TAPS: an early detection of cancer technology that uses blood-based testing Anneliese viewing cancer big data information presented by Eva Morris, Jens Rittscher and Sharib AliAnneliese viewing cancer big data information presented by Eva Morris, Jens Rittscher and Sharib Ali

 Anneliese went on to meet with theme leaders from our Cancer Big Data activity happening at the Big Data Institute. They discussed the important work happening through the use of electronic health records to identify and address health inequalities and improve the health care system. Followed by a demonstration of the work using AI to detect cancer in novel way, such as its applications in identifying oesophageal cancer through endoscopy videos. 

Anneliese viewing work at the IBME with Laura Spiers and Tamsyn Clarke - who are working on improving cancer drug delivery through the physical sciencesAnneliese viewing work at the IBME with Laura Spiers and Tamsyn Clarke - who are working on improving cancer drug delivery through the physical sciences Anneliese talking with clinical researcher Sarah Blagden about the scope of cancer clinical trials happening in OxfordAnneliese talking with clinical researcher Sarah Blagden about the scope of cancer clinical trials happening in Oxford

The tour also touched on the vital work of the physical sciences, such as researchers from the PanDox trial at the Institute for Biomedical Engineering who are applying novel engineering approaches to improve the delivery of drugs in a more targeted way. Before ending on the clinical applications of all this work which are being delivered through the important clinical trials units at the Oxford University Hospitals NHS Foundation Trust, which are dedicated to testing new and improved treatments for cancer.

 

It was fantastic to see the diversity of disciplines here in Oxford that are contributing to ongoing improvements in cancer patient care. There are some cutting-edge projects happening that will ultimately benefit many through cancer early detection, diagnosis and treatment.

This tour has underlined that Oxford and the wider UK can be a science superpower. To do this the UK Government must invest in the thriving life sciences sector, in order to deliver on its commitments to those affected by cancer.- Anneliese Dodds, MP for Oxford East & Chair of the Labour Party


Similar stories

New blood-based test is the first ever to simultaneously identify if a patient has cancer and if it has spread

A publication by University of Oxford researchers describes a new minimally invasive and inexpensive blood test that can identify cancer in patients with non-specific symptoms. The early success of this technology makes it the first blood-based test that not only detects cancer in this population but can simultaneously identify if a cancer has spread.

Eileen Parkes secures Clinical Research Career Development Fellowship

Eileen is awarded funding for her research into the tumour microenvironment

World’s first cancer prevention trial to test diabetes drug in patients with high-risk genetic condition

Oxford researchers will lead a £2m national cancer prevention trial to assess the benefit a diabetes drug has in patients with Li Fraumeni Syndrome (LFS), a genetic condition that impacts 1 in 20,000 people worldwide and puts them at a 70-90% lifetime risk of cancer.

Anti-cancer drug derived from fungus shows promise in clinical trials

A new industry-academic partnership between the University of Oxford and biopharmaceutical company NuCana has found that chemotherapy drug NUC-7738, derived from a Himalayan fungus, has 40 times greater potency for killing cancer cells than its parent compound.

Further funding secured to hunt out cancer using innovative radiotherapy techniques

Initial success leads to new award for Oxford researcher pushing forward new cancer-hunting radiotherapy despite lockdown.